Alberto Piubello Selected Research

Hearing Loss (Hearing Impairment)

1/2021	High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
6/2020	Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Piubello Research Topics

Disease

15	Tuberculosis (Tuberculoses) 08/2023 - 12/2019
3	Ototoxicity 12/2022 - 06/2020
2	Hearing Loss (Hearing Impairment) 01/2021 - 06/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 01/2020
1	Drug-Related Side Effects and Adverse Reactions 08/2023
1	Leprosy (Hansen's Disease) 05/2023

Drug/Important Bio-Agent (IBA)

13	Rifampin (Rifampicin)FDA LinkGeneric 08/2023 - 01/2020
2	bedaquiline (R207910)IBA 05/2023 - 01/2020
2	Linezolid (Zyvox)FDA Link 12/2022 - 01/2021
2	FluoroquinolonesIBA 01/2020 - 12/2019
1	Isoniazid (Ftivazide)FDA LinkGeneric 08/2023
1	Kanamycin FDA Link 06/2020

Therapy/Procedure

3	Injections 12/2022 - 06/2020
1	Retreatment 01/2023
1	Continuity of Patient Care 11/2020
1	Aftercare (After-Treatment) 03/2020